Drug points: Fatal lactic acidosis associated with tenofovir

British Medical Journal

Volumn 327, Issue 7417, 2003, Pages 711-

  Rivas, Pablo ^a   Polo, Jorge ^a   De Górgolas, Miguel ^a   Fernández Guerrero, Manuel L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BILIRUBIN; DIDANOSINE; DNA DIRECTED DNA POLYMERASE GAMMA; LACTIC ACID; LIVER ENZYME; MITOCHONDRIAL DNA; NEVIRAPINE; PROTHROMBIN; RIBOFLAVIN; STAVUDINE; TENOFOVIR; THIAMINE; TRIACYLGLYCEROL LIPASE; VITAMIN K GROUP;

ABDOMINAL PAIN; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PH; CASE REPORT; CLINICAL FEATURE; DISORIENTATION; DRUG FATALITY; DRUG SAFETY; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; HEPATITIS C; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; JAUNDICE; LACTIC ACIDOSIS; MITOCHONDRION; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; PROTHROMBIN TIME; SIDE EFFECT; VOMITING;

ACIDOSIS, LACTIC; ADENINE; ANTI-HIV AGENTS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0141869019     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. FDA approves Viread for HIV-1 infection. FDA Consum 2002;36:5.
2. Cheng A, Barriere S, Coackley DF, Chen SS, Wulfsohn M, Toole JJ. Safety profile of Tenofovir DF in antiretroviral treatment-experienced patients from randomized, double-blind, placebo-controlled clinical trials. 14th International AIDS Conference, Barcelona, July 2002. (Abstract No TuPeB4460.)
3. Birkus G, Hitchcock MJ, Cihlar T. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 2002;46:716-23.
4. Kakuda TN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000;22:685-708.
5. Kearney BP, Damle B, Plummer A, Sayre J, Zhang X, Ryan K, et al. Tenofovir DF (TDF) and Didanosine EC (ddI EC): investigation of pharmacokinetic (PK) drug-drug and drug-food interactions. 14th International AIDS Conference, Barcelona, July 2002. (Abstract No LbPeB9026.)